Type 2 Diabetes Study

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

Criteria
Inclusion Criteria:
• Participants with a diagnosis of type 2 diabetes mellitus (T2DM)
• Random C-peptide at screening greater than (>)0.6 nanogram/milliliter (ng/mL) (>0.2 nanomole/liter [nmol]/L])
• HbA1c of greater than or equal to (>=)6.5 percent (%) to less than or equal to (<=)10.5% and either
1. On diet and exercise alone during the 8 weeks prior to screening
2. On diet and exercise and a stable dose of metformin monotherapy >=1,000 mg per day for at least 8 weeks prior to screening
3. On diet and exercise and a stable insulin monotherapy regimen for at least 8 weeks prior to screening
4. On diet and exercise and a stable combination therapy with metformin and insulin for at least 8 weeks prior to screening

Exclusion Criteria:
• History of diabetic ketoacidosis (DKA), type 1 diabetes mellitus (T1DM), pancreas or cell transplantation, or diabetes secondary to pancreatitis or pancreatectomy or maturity onset diabetes of the young (MODY)
• Participants on any antihyperglycemic agents (AHAs) other than metformin, or injectable insulin within 8 weeks of the first dose of study drug (Day 1)
• Repeated (2 or more over a 1-week period) fasting self-monitoring of blood glucose (SMBG) measurements >270 milligram/deciliter (mg/dL) (>15 millimole/liter [mmol/L]) during the pretreatment phase, despite reinforcement of diet and exercise counseling
• Severe hypoglycemia within 6 months prior to Day 1
• History of hereditary glucose-galactose malabsorption or primary renal glucosuria

CALL NOW TO BOOK YOUR 

FREE CONSULTATION 

954-391-2477

CHAT LIVE BELOW WITH ANY QUESTIONS

Book a Free Consultation

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease (COGNITE)

We are currently providing memory screenings for our mild cognitive impairment study/ Early Alzheimer. 
 
To qualify, eligible participants must:
• Be between 55 and 79 years old
• Have at least 8 years of education
• Have noticed changes in their memory, or have been told by a loved one that they are concerned about their memory problems
• Have noticed changes in their normal, everyday behavior
• Attend all study visits with a willing and able study partner with whom they have frequent contact
• Be in good general health

CALL NOW TO BOOK YOUR 

FREE MEMORY SCREENING 

954-391-2477

(NO INSURANCE REQUIRED)

CHAT LIVE BELOW WITH ANY QUESTIONS

Book a Free Memory Screening

Our Current Clinical Trials

At TOPAZ Clinical Research in Apopka, FL, we want the experience to be as hassle-free and beneficial as possible for our volunteer patients. Our staff will work hard to arrange your appointments around your schedule, outline time commitments clearly, and walk you through the entire process patiently.

When you get involved in our clinical research, you can contribute to the development and marketing of the following:

  • Biological products
  • Medical devices
  • New drugs
  • Treatments
  • And more
Veteran Owned Business